16.08.2016 Views

Master the board step 3

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Oncology<br />

Aromatase inhibitors are pure estrogen antagonists. They do not have <strong>the</strong><br />

selective estrogen receptor agonist (stimulatory) activity that tamoxifen does.<br />

Aromatase inhibitors (anastrozole, letrozole, exemestane) do not lead to DVT,<br />

but <strong>the</strong>y can lead to osteoporosis, because <strong>the</strong>y are antagonistic to estrogen<br />

receptors in <strong>the</strong> bone.<br />

Adjuvant Chemo<strong>the</strong>rapy<br />

Adjuvant chemo<strong>the</strong>rapy is appropriate under <strong>the</strong> following circumstances:<br />

··<br />

Cancer is in <strong>the</strong> axilla.<br />

··<br />

Cancer is larger than 1 cm.<br />

··<br />

It is more efficacious when <strong>the</strong> patient is still menstruating. Breast cancer in<br />

menstruating women will not likely be controlled with estrogen antagonists,<br />

such as tamoxifen or aromatase inhibitors.<br />

Tamoxifen decreases risk<br />

of breast cancer. BRCA<br />

does not.<br />

Trastuzumab<br />

··<br />

A monoclonal antibody against <strong>the</strong> breast cancer antigen HER-2/NEU<br />

··<br />

Useful in metastatic disease<br />

··<br />

Modest efficacy with few adverse effects<br />

Colon Cancer<br />

The most important knowledge to have for Step 3 is <strong>the</strong> screening schedule and<br />

indicators. Colon cancer is treated with surgical resection of <strong>the</strong> colon and<br />

chemo<strong>the</strong>rapy centered around a 5-fluorouracil regimen if high-risk stage 2<br />

cancer or stage 3 or more.<br />

279

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!